Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Modern laboratories rely on ultra-high-throughput screening (UHTS) to systematically evaluate chemical compounds or biological targets at massive scales. Depending on system configuration, these ...
This article is based on a poster originally authored by Ariane Jonetz-Mentzel et al. In biopharmaceutical laboratories, there is an increasing demand for label-free, high-throughput screening based ...